301 related articles for article (PubMed ID: 12974737)
21. Supporting disclosure of genetic information to family members: professional practice and timelines in cancer genetics.
Derbez B; de Pauw A; Stoppa-Lyonnet D; de Montgolfier S
Fam Cancer; 2017 Jul; 16(3):447-457. PubMed ID: 28293859
[TBL] [Abstract][Full Text] [Related]
22. Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives.
Ormondroyd E; Moynihan C; Watson M; Foster C; Davolls S; Ardern-Jones A; Eeles R
J Genet Couns; 2007 Aug; 16(4):527-38. PubMed ID: 17492498
[TBL] [Abstract][Full Text] [Related]
23. Experiences of genetic risk: disclosure and the gendering of responsibility.
d'Agincourt-Canning L
Bioethics; 2001 Jun; 15(3):231-47. PubMed ID: 11700677
[TBL] [Abstract][Full Text] [Related]
24. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
25. "I Don't Want to Be an Ostrich": Managing Mothers' Uncertainty during BRCA1/2 Genetic Counseling.
Fisher CL; Roccotagliata T; Rising CJ; Kissane DW; Glogowski EA; Bylund CL
J Genet Couns; 2017 Jun; 26(3):455-468. PubMed ID: 27473644
[TBL] [Abstract][Full Text] [Related]
26. How young people find out about their family history of Huntington's disease.
Forrest Keenan K; van Teijlingen E; McKee L; Miedzybrodzka Z; Simpson SA
Soc Sci Med; 2009 May; 68(10):1892-900. PubMed ID: 19328606
[TBL] [Abstract][Full Text] [Related]
27. Dealing with the uncertainty of developing a cancer.
Murphy AE
Eur J Cancer Care (Engl); 1999 Dec; 8(4):233-7. PubMed ID: 10889621
[TBL] [Abstract][Full Text] [Related]
28. What do we tell the children? Contrasting the disclosure choices of two HD families regarding risk status and predictive genetic testing.
Holt K
J Genet Couns; 2006 Aug; 15(4):253-65. PubMed ID: 16850280
[TBL] [Abstract][Full Text] [Related]
29. Preparing young people for future decision-making about cancer risk in families affected or at risk from hereditary breast cancer: A qualitative interview study.
Rowland E; Plumridge G; Considine AM; Metcalfe A
Eur J Oncol Nurs; 2016 Dec; 25():9-15. PubMed ID: 27865258
[TBL] [Abstract][Full Text] [Related]
30. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
31. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
[TBL] [Abstract][Full Text] [Related]
32. Patient-reported anticipated barriers and benefits to sharing cancer genetic risk information with family members.
Finn KS; Pacyna J; Azevedo Tsou C; Jewel Samadder N; Sharp R
Eur J Hum Genet; 2022 Jan; 30(1):53-61. PubMed ID: 33867528
[TBL] [Abstract][Full Text] [Related]
33. Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires--an Italian exploratory study.
Catania C; Feroce I; Barile M; Goldhirsch A; De Pas T; de Braud F; Boselli S; Adamoli L; Radice D; Rossi A; Spitaleri G; Noberasco C; Bonanni B
J Cancer Res Clin Oncol; 2016 Mar; 142(3):633-48. PubMed ID: 26577826
[TBL] [Abstract][Full Text] [Related]
34. A qualitative study exploring genetic counsellors' experiences of counselling children.
Ulph F; Leong J; Glazebrook C; Townsend E
Eur J Hum Genet; 2010 Oct; 18(10):1090-4. PubMed ID: 20531440
[TBL] [Abstract][Full Text] [Related]
35. How hereditary cancer risk disclosure to relatives is handled in practice - Patient perspectives from a Swedish cancer genetics clinic.
Hawranek C; Rosén A; Hajdarevic S
Patient Educ Couns; 2024 Sep; 126():108319. PubMed ID: 38788311
[TBL] [Abstract][Full Text] [Related]
36. Utility and limitations of genetic testing and information.
Bradley AN
Nurs Stand; 2005 Oct 12-18; 20(5):52-5. PubMed ID: 16255487
[TBL] [Abstract][Full Text] [Related]
37. Patients' Attitudes Towards Disclosure of Genetic Test Results to Family Members: The Impact of Patients' Sociodemographic Background and Counseling Experience.
Gilbar R; Shalev S; Spiegel R; Pras E; Berkenstadt M; Sagi M; Ben-Yehuda A; Mor P; Perry S; Zaccai TF; Borochowitz Z; Barnoy S
J Genet Couns; 2016 Apr; 25(2):314-24. PubMed ID: 26371363
[TBL] [Abstract][Full Text] [Related]
38. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning.
Koehly LM; Peterson SK; Watts BG; Kempf KK; Vernon SW; Gritz ER
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):304-13. PubMed ID: 12692104
[TBL] [Abstract][Full Text] [Related]
39. Disclosure of Huntington's disease to family members: the dilemma of known but unknowing parties.
Hakimian R
Genet Test; 2000; 4(4):359-64. PubMed ID: 11216659
[TBL] [Abstract][Full Text] [Related]
40. Knowledge and expectations of women undergoing cancer genetic risk assessment: a qualitative analysis of free-text questionnaire comments.
Phelps C; Wood F; Bennett P; Brain K; Gray J
J Genet Couns; 2007 Aug; 16(4):505-14. PubMed ID: 17318449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
